$BLKB

BLACKBAUD INC (BLKB): Submission of Matters to a Vote of Security Holders

BLACKBAUD INC (BLKB) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. blkb-20260610 false 0001280058 0001280058 2026-06-10 2026-06-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):

Original reporting
Published Jun 11, 2026, 8:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$BLKB
Neutral
medium confidence
Mentioned
$BLKB
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BLKBNeutralLow
01

Why it matters

Confirms shareholder approval of (1) advisory executive compensation, (2) amendment/restatement of the 2016 equity and incentive compensation plan, and (3) ratification of Ernst & Young LLP for FY ending Dec. 31, 2026.

02

Market read

Routine governance outcomes; useful for long-only governance monitoring but not a direct catalyst for earnings or cash-flow expectations.

03

What to watch

Traders may instead focus on whether the equity plan amendment enables future share-based compensation capacity, but the filing does not quantify incremental dilution or timing.

Relevance 6/10Novelty 4/10Timing: after-hours/filing day (2026-06-11)

Background

The SEC 8-K Item 5.07 reports results from Blackbaud’s June 10, 2026 annual stockholder meeting.

Company-level read

Ticker impact

$BLKBNeutralMedium confidence
Context

Blackbaud reported 2026 annual meeting voting results, including advisory approval of 2025 named executive officer compensation and plan amendment/restatement.

Expected impact

Likely limited near-term impact; any reaction would be modest unless vote margins signal governance controversy.

Evidence & confidence

The filing discloses only shareholder vote tallies (no new financial guidance, deal, or enforcement action).

Market effects

Minimal; this is company-specific governance/compensation and equity-plan administration.

None indicated.

None indicated.

Counterpoint

If vote margins were unusually close, it could hint at governance dissatisfaction that may affect future proposals, but the article provides no qualitative context beyond tallies.

Key entities

  • Blackbaud, Inc.

    Company filing the 8-K and subject of the shareholder vote results.

  • Ernst & Young LLP

    Ratified as independent registered public accounting firm for FY ending Dec. 31, 2026.

Related articles

$BLKBMedAI 8/10

Why Blackbaud Stock Is Skyrocketing Today

Blackbaud (BLKB) shares rose about 20.5% on Wednesday after the company’s Q2 results. Blackbaud reported non-GAAP earnings of $1.33 on revenue of $290.6 million, with adjusted EPS above estimates but sales $1.76 million below. It reiterated full-year adjusted EPS guidance of $5.15 to $5.25 and said results are expected in the upper half of guidance.

$BLKBMedAI 8/10

Blackbaud Announces 2026 Second Quarter Results

Blackbaud (NASDAQ: BLKB) reported Q2 2026 results for the quarter ended June 30, 2026. GAAP total revenue was $290.6 million (+3.0%) and GAAP diluted EPS was $0.79. Non-GAAP diluted EPS was $1.33. The company expects FY2026 to finish in the upper half of guidance, including GAAP revenue $1.173B-$1.179B and non-GAAP FCF $280M-$290M, and reiterated repurchases of 6%-10% of shares.

$BLKBMed

BLACKBAUD INC (BLKB): Results of Operations and Financial Condition

BLACKBAUD INC (BLKB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 blkbq22026exhibit991.htm EX-99.1 Document Exhibit 99.1 PRESS RELEASE Blackbaud Announces 2026 Second Quarter Results Company Expects to Finish Fiscal Year 2026 in the Upper Half of Financial Guidance Ranges Charleston, S.C. (July 29, 2026) — Blackbaud (NASDAQ: BLKB), th

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.